Page last updated: 2024-10-25

eflornithine and Lupus Nephritis

eflornithine has been researched along with Lupus Nephritis in 2 studies

Eflornithine: An inhibitor of ORNITHINE DECARBOXYLASE, the rate limiting enzyme of the polyamine biosynthetic pathway.
eflornithine : A fluoroamino acid that is ornithine substituted by a difluoromethyl group at position 2.

Lupus Nephritis: Glomerulonephritis associated with autoimmune disease SYSTEMIC LUPUS ERYTHEMATOSUS. Lupus nephritis is histologically classified into 6 classes: class I - normal glomeruli, class II - pure mesangial alterations, class III - focal segmental glomerulonephritis, class IV - diffuse glomerulonephritis, class V - diffuse membranous glomerulonephritis, and class VI - advanced sclerosing glomerulonephritis (The World Health Organization classification 1982).

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hsu, HC1
Thomas, T1
Seibold, JR2
Thomas, TJ2
Gunnia, UB1
Amenta, PS1

Other Studies

2 other studies available for eflornithine and Lupus Nephritis

ArticleYear
Studies on the effects of an ornithine decarboxylase inhibitor on lupus nephritis reveal a post-transcriptional modification of the enzyme.
    Agents and actions, 1993, Volume: 39 Spec No

    Topics: Animals; Blotting, Northern; Eflornithine; Female; Kidney; Lupus Nephritis; Mice; Mice, Inbred BALB

1993
Successful treatment of lupus nephritis in MRL-lpr/lpr mice by inhibiting ornithine decarboxylase.
    Kidney international, 1991, Volume: 39, Issue:5

    Topics: Animals; Antibodies, Antinuclear; Disease Models, Animal; Dose-Response Relationship, Drug; Eflornit

1991